DeciBio
Andrew Aijian has a diverse background in biomedical engineering, with experience in research and consulting roles. At DeciBio, Andrew has held various titles including Partner, Principal, and Sr. Project Leader, where Andrew is involved in market research and strategy consulting for life-science companies. Prior to that, Andrew was a Graduate Student and Researcher at UCLA and an Intern at Sandia National Laboratories. Andrew holds a Ph.D. and Master's degree in Biomedical Engineering from UCLA and a B.S. in Chemical and Biomolecular Engineering from the University of Notre Dame.
DeciBio
1 followers
DeciBio Consulting is a boutique strategy consulting firm focusing on the life science industry. DeciBio's mission is to provide the strategic insights that accelerate the development, adoption, and accessibility of personalized medicine. Headquartered in Los Angeles, CA, DeciBio serves clients and customers across the globe, ranging from incubator-stage startups to Fortune 500 life science corporations. DeciBio addresses business solutions that range from market landscape analyses to full commercial strategies, including organic and inorganic growth opportunities (commercial due diligences). DeciBio’s work is typically supported by a mix of primary and secondary research leveraging Dexter, its in-house expert network, and DeciBio Analytics’ proprietary data intelligence products. DeciBio’s Analytics division offers numerous data products to support strategic insights, including in clinical diagnostics (the DxBooks), immuno-oncology (the I/O BioMAP), omics market segmentation (the MarketBooks), and the entire life sciences industry (BioTrack). Internal teams such as the Culture Committee, Women* in Consulting, and Gays in Consulting enrich the employee experience. DeciBio’s Social Impact board and the DeciBio Impact Lab work collaboratively across divisions and externally to uproot discrimination and increase access to precision medicine.